is glp-1 safe receptor agonists A monthly GLP-1 dose could

You do not need to prime before every injection

Beyond their blood sugar-lowering effects, certain medicationssuch as liraglutide, semaglutide, and tirzepatidehave demonstrated significant effectiveness in promoting weight management, and they have been approved by the Food and Drug Administration (FDA) for long-term obesity treatment

These numbers are meaningfully higher than tirzepatide discontinuation rates and represent an important consideration for researchers planning long-term protocols

The SURMOUNT-OSA trial reported that tirzepatide reduced the apnea-hypopnea index by 25% to 29% over 52 weeks in individuals with obesity and moderate to severe OSA, compared with a reduction of 5.3% to 5.5% in the placebo group, regardless of the use of positive airway pressure therapy (19)